In Vitro Evaluation of p-Toluenesulfonyl Hydrazones as Anti-Trypanosoma cruzi and Leishmanicidal Agents.

IF 2.6 4区 医学 Q3 CHEMISTRY, MEDICINAL
Eya Caridad, Timoteo Delgado-Maldonado, Diana V Navarrete-Carriola, Lenci K Vázquez-Jiménez, Eyra Ortiz-Perez, Alma D Paz-González, Ignacio Martinez, Bertha Espinoza, Gildardo Rivera
{"title":"<i>In Vitro</i> Evaluation of <i>p</i>-Toluenesulfonyl Hydrazones as Anti-<i>Trypanosoma cruzi</i> and Leishmanicidal Agents.","authors":"Eya Caridad, Timoteo Delgado-Maldonado, Diana V Navarrete-Carriola, Lenci K Vázquez-Jiménez, Eyra Ortiz-Perez, Alma D Paz-González, Ignacio Martinez, Bertha Espinoza, Gildardo Rivera","doi":"10.2174/0115734064390136250818063436","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Neglected tropical diseases (NTDs), such as Chagas disease (CD) and Cutaneous Leishmaniasis (CL), are significant global health concerns. The limited number of treatments and their severe adverse effects worsen the situation. Therefore, the development of molecules as a new pharmacological alternative is necessary. This work aimed to obtain new p- Toluenesulfonyl hydrazones derivatives to determine their potential antiparasitic activity against <i>Trypanosoma cruzi (T. cruzi)</i> and <i>Leishmania mexicana (L. mexicana)</i>.</p><p><strong>Methods: </strong>Compounds were synthesized by condensing p-Toluenesulfonyl hydrazide with aromatic aldehydes using acetic acid as a catalyst. All compounds were structurally elucidated using infrared (IR) spectroscopy, proton and carbon nuclear magnetic resonance (¹H and ¹³C NMR), and Ultra-Performance Liquid Chromatography-tandem Mass Spectrometry (UPLCMS). The Queretaro (Qro) strain of <i>T. cruzi</i> and the M379 strain of <i>L. mexicana</i> were used for <i>in vitro</i> assays.</p><p><strong>Results: </strong>Compound pT-21 (IC<sub>50</sub>= 49.6 μM) was the most active agent against the <i>T. cruzi</i> Qro strain. Meanwhile, compounds pT-15 and pT-21 inhibited the proliferation of <i>L. mexicana</i> promastigotes with an IC<sub>50</sub> value of 59.2 and 13.8 μM, respectively. In addition, these compounds had low cytotoxic effects against Vero cell lines (CC<sub>50</sub> values >100 μM).</p><p><strong>Discussion: </strong>In this study, compound pT-21 inhibited the proliferation of <i>T. cruzi</i> and <i>L. mexicana in vitro</i>. Its activity is attributed to the reactivity of the 5-nitrofuran ring (present in other drugs such as nifurtimox). Future research could focus on identifying the pharmacological target of compound pT-21 to facilitate rational drug design and enhance its potency against these parasites.</p><p><strong>Conclusion: </strong>In summary, these results show that p-Toluenesulfonyl hydrazones serve as a scaffold to aid in the development of potent and selective agents against <i>T. cruzi</i> and <i>L. mexicana</i>.</p>","PeriodicalId":18382,"journal":{"name":"Medicinal Chemistry","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115734064390136250818063436","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Neglected tropical diseases (NTDs), such as Chagas disease (CD) and Cutaneous Leishmaniasis (CL), are significant global health concerns. The limited number of treatments and their severe adverse effects worsen the situation. Therefore, the development of molecules as a new pharmacological alternative is necessary. This work aimed to obtain new p- Toluenesulfonyl hydrazones derivatives to determine their potential antiparasitic activity against Trypanosoma cruzi (T. cruzi) and Leishmania mexicana (L. mexicana).

Methods: Compounds were synthesized by condensing p-Toluenesulfonyl hydrazide with aromatic aldehydes using acetic acid as a catalyst. All compounds were structurally elucidated using infrared (IR) spectroscopy, proton and carbon nuclear magnetic resonance (¹H and ¹³C NMR), and Ultra-Performance Liquid Chromatography-tandem Mass Spectrometry (UPLCMS). The Queretaro (Qro) strain of T. cruzi and the M379 strain of L. mexicana were used for in vitro assays.

Results: Compound pT-21 (IC50= 49.6 μM) was the most active agent against the T. cruzi Qro strain. Meanwhile, compounds pT-15 and pT-21 inhibited the proliferation of L. mexicana promastigotes with an IC50 value of 59.2 and 13.8 μM, respectively. In addition, these compounds had low cytotoxic effects against Vero cell lines (CC50 values >100 μM).

Discussion: In this study, compound pT-21 inhibited the proliferation of T. cruzi and L. mexicana in vitro. Its activity is attributed to the reactivity of the 5-nitrofuran ring (present in other drugs such as nifurtimox). Future research could focus on identifying the pharmacological target of compound pT-21 to facilitate rational drug design and enhance its potency against these parasites.

Conclusion: In summary, these results show that p-Toluenesulfonyl hydrazones serve as a scaffold to aid in the development of potent and selective agents against T. cruzi and L. mexicana.

对甲苯磺酰腙抗克氏锥虫和利什曼尼虫的体外评价。
被忽视的热带病(NTDs),如恰加斯病(CD)和皮肤利什曼病(CL),是重大的全球卫生问题。有限的治疗方法及其严重的副作用使情况更加恶化。因此,开发分子作为一种新的药理替代品是必要的。本文旨在获得新的对甲苯磺酰腙衍生物,以测定其对克氏锥虫和墨西哥利什曼原虫的潜在抗寄生活性。方法:以乙酸为催化剂,对甲苯磺酰肼与芳香醛缩合合成化合物。所有化合物均通过红外(IR)光谱、质子和碳核磁共振(¹H和¹³C NMR)、超高效液相色谱-串联质谱(UPLCMS)进行结构鉴定。采用克氏T.克氏T.克雷塔罗(Qro)菌株和墨西哥L. M379菌株进行体外检测。结果:化合物pT-21 (IC50= 49.6 μM)对克氏锥虫Qro菌的抑菌活性最强。化合物pT-15和pT-21对L. mexicana promastigotes的增殖有抑制作用,IC50值分别为59.2 μM和13.8 μM。此外,这些化合物对Vero细胞系具有较低的细胞毒作用(CC50值为bb0 ~ 100 μM)。讨论:在本研究中,化合物pT-21在体外抑制克氏T.和墨西哥L.的增殖。其活性归因于5-硝基呋喃环的反应性(存在于其他药物如硝呋替莫中)。今后的研究重点应放在确定化合物pT-21的药理学靶点上,以促进合理的药物设计,提高其抗寄生虫的效力。结论:综上所述,对甲苯磺酰腙可作为抗克氏T. cruzi和墨西哥L. mexicana强效和选择性药物的骨架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medicinal Chemistry
Medicinal Chemistry 医学-医药化学
CiteScore
4.30
自引率
4.30%
发文量
109
审稿时长
12 months
期刊介绍: Aims & Scope Medicinal Chemistry a peer-reviewed journal, aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design. The journal publishes original research, mini-review articles and guest edited thematic issues covering recent research and developments in the field. Articles are published rapidly by taking full advantage of Internet technology for both the submission and peer review of manuscripts. Medicinal Chemistry is an essential journal for all involved in drug design and discovery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信